Aquestive Therapeutics, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Daniel Barber, with a market cap of $511.8M.
Based on Q1 2026 filing
Common questions about Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) has a market capitalization of $511.8M and trades on NASDAQ.
Aquestive Therapeutics, Inc. has approximately 135 employees.